Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Eur J Gastroenterol Hepatol. 2022 Jan 1;34(1):33–38. doi: 10.1097/MEG.0000000000002052

Table 1:

Final multivariable prediction model*

Predictor β Coefficient SE Odds ratio
(OR)
95%CI P-value
Anthropometry
Age 0.045648 0.0074286 1.05 1.03-1.06 <0.001
BMI −0.0386336 0.0148288 0.96 0.93-0.99 0.012
Medication use
PPIs 0.4307414 0.2344925 1.54 1.14-2.07 0.005
Laboratory studies
Total cholesterol (mmol/L) −0.2418048 0.1040687 0.79 0.61-1.02 0.068
LDL (mmol/L) 0.1995238 0.3666574 1.22 0.68-2.20 0.507
LDL2 0.0101408 0.0332521 1.01 0.95-1.08 0.758
Alkaline phosphatase (U/L) 0.0057762 0.0013348 1.01 1.00-1.01 <0.001
Alkaline phosphatase2 −2.00e-06 1.05e-06 0.99 0.9999959-1.0 0.057
ALT (U/L) 0.0099102 0.0025566 1.01 1.00-1.01 <0.001
ALT2 −6.44e-06 3.48e-06 0.99 0.9999867-1.0 0.064
Intercept −8.735021 0.0001462
*

The formula of the resulting prediction model is:

P3-year probability for pancreatic cancer following diabetes diagnosis = e(Xβ)/1+ e(Xβ)

Xβ = 0.045648 x age − 0.0386336 x BMI + 0.4307414 x PPIs − 0.2418048 x total cholesterol + 0.1995238 LDL + 0.0101408 x LDL2 + 0.0057762 x alkaline phosphatase − 2.00e-06 alkaline phosphatase2 + 0.0099102 x ALT − 6.44e-06 − 8.735021